Elekta introduces AI-powered and Adaptable CT-Linac Evo in India

News Desk, News Nation 360 : Elekta has announced the launch of its latest linear accelerator (Linac), Evo, in the Indian market. Evo, which has already been deployed in Europe and other places, is now accessible in India, providing clinicians with high-definition AI-enhanced imaging and adaptive radiation therapy capabilities. This highly adaptable CT-Linac will allow clinicians to select the most appropriate radiation therapy technique for each patient. Evo was shown for the first time in India during the Association of Radiation Oncologists of India Conference (AROICON) in Kolkata, the country's largest industry event in radiation oncology. Shankar Seshadri, VP & Head - India Sub-continent, added that India requires radiation solutions that combine precision and practicality, and Evo is uniquely positioned to meet India's expanding cancer load and changing patient needs. Its adaptable capabilities and efficient workflow enable high-volume facilities to serve more patients while maintaining treatment quality. The introduction of Evo in India is a key milestone because it will accelerate our market expansion in the area. Adaptive radiotherapy (ART) with Elekta Evo offers a state-of-the-art approach to cancer treatment, where the radiation

plan dynamically adapts to take into account changes in the patient's anatomy or tumour throughout therapy. The Elekta Evo includes an AI-enhanced Iris®™ high-definition imaging system that provides exceptional clarity for visualising tumours and organs at risk, so critical for precision contouring and treatment delivery. It is integrated with the Elekta ONE Online software, which automates workflow through faster dose calculation, AI-driven auto-contouring, plan adaptation, and comprehensive quality assurance, allowing for both online and offline adaptive radiotherapy. These technological advancements result in greater personalisation, enhanced safety through the minimisation of unnecessary exposure to healthy tissues, and allow treatments to adapt in near real-time while maintaining the high throughput within typical clinical session times. Certified with CDSCO registration in India, Elekta Evo supports a wide range of cancer indications with proven precision features, including FFF beams and 6D couch adjustments. This empowers clinicians to offer highly tailored, efficient, and globally benchmarked radiotherapy, potentially offering improvements in patient outcomes and quality of life.

Pic - Courtesy